Breathalyzer App Barred from Making False Accuracy Claims

Breathometer, Inc. and its founder that sold app-supported devices that claimed to accurately measure consumers’ blood alcohol content (BAC) through government-lab testing agreed to settle Federal Trade Commission charges that they lacked scientific evidence to back up their advertising claims. They are barred from making future accuracy claims for a consumer breathalyzer product unless such claims are supported by rigorous testing and must provide consumers with refunds. The FTC found that the products understated BAC levels making them dangerous for users, who relied on them before driving a vehicle. Andersen Sleater Sianni also represents consumers, who may have been victimized by relying on products' false representations and claims like the breathometer. Click here to read more about the FTC's action against this company.